Zhang Lab

University of Michigan

Home Research COVID-19 Services Publications People Teaching Job Opening News Forum Lab Only

Online Services

●I-TASSER ●I-TASSER-MTD ●C-I-TASSER ●CR-I-TASSER ●QUARK ●C-QUARK ●LOMETS ●MUSTER ●CEthreader ●SEGMER ●DeepFold ●DeepFoldRNA ●FoldDesign ●COFACTOR ●COACH ●MetaGO ●TripletGO ●IonCom ●FG-MD ●ModRefiner ●REMO ●DEMO ●DEMO-EM ●DMFold ●SPRING ●COTH ●Threpp ●PEPPI ●BSpred ●ANGLOR ●EDock ●BSP-SLIM ●SAXSTER ●FUpred ●ThreaDom ●ThreaDomEx ●EvoDesign ●BindProf ●BindProfX ●SSIPe ●GPCR-I-TASSER ●MAGELLAN ●ResQ ●STRUM ●DAMpred

●TM-score ●TM-align ●US-align ●MM-align ●RNA-align ●NW-align ●LS-align ●EDTSurf ●MVP ●MVP-Fit ●SPICKER ●HAAD ●PSSpred ●3DRobot ●MR-REX ●I-TASSER-MR ●SVMSEQ ●NeBcon ●ResPRE ●TripletRes ●DeepPotential ●WDL-RF ●ATPbind ●DockRMSD ●DeepMSA ●FASPR ●EM-Refiner ●GPU-I-TASSER

●BioLiP ●E. coli ●GLASS ●GPCR-HGmod ●GPCR-RD ●GPCR-EXP ●Tara-3D ●TM-fold ●DECOYS ●POTENTIAL ●RW/RWplus ●EvoEF ●HPSF ●THE-DB ●ADDRESS ●Alpaca-Antibody ●CASP7 ●CASP8 ●CASP9 ●CASP10 ●CASP11 ●CASP12 ●CASP13 ●CASP14

GLASS

You can:

Go to the GPCR, ligand, or experimental data tables.
Go to the experimental data table for text mining information in PubMed ID column.
Go to the GPCR page and check other ligands which interact with it.
Go to the ligand page and check other GPCRs which it interacts with.
Go back to previous page.

GPCR

Name	Muscarinic acetylcholine receptor M4
Species	Homo sapiens (Human)
Gene	CHRM4
Synonym	HM3 M4 receptor cholinergic receptor Chrm-4 cholinergic receptor, muscarinic 4
Disease	Produce mydriasis and cycloplegia for diagnostic purposes Hypertension Irritable bowel syndrome Moderate and severe psychomotor agitation Mydriasis diagnosis Nausea; Vomiting; Emesis Organophosphate poisoning Overactive bladder disorder; Spasm Parkinson's disease Urinary retention Peptic ulcer Peptic ulcer disease; Irritable bowel syndrome; Pancreatitis; Gastritis Solid tumours Peptic ulcer; Gastrointestinal disease Peptic ulcer; Uveitis Glaucoma Gastrointestinal disease Bronchodilator Poison intoxication Chronic obstructive pulmonary disease Cough Central and peripheral nervous diseases Depression Alzheimer disease Dysuria; Urgency; Nocturia; Suprapubic pain Gastric motility disorder; Spasm Acquired nystagmus [ Show all ]
Length	479
Amino acid sequence	MANFTPVNGSSGNQSVRLVTSSSHNRYETVEMVFIATVTGSLSLVTVVGNILVMLSIKVNRQLQTVNNYFLFSLACADLIIGAFSMNLYTVYIIKGYWPLGAVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPARRTTKMAGLMIAAAWVLSFVLWAPAILFWQFVVGKRTVPDNQCFIQFLSNPAVTFGTAIAAFYLPVVIMTVLYIHISLASRSRVHKHRPEGPKEKKAKTLAFLKSPLMKQSVKKPPPGEAAREELRNGKLEEAPPPALPPPPRPVADKDTSNESSSGSATQNTKERPATELSTTEATTPAMPAPPLQPRALNPASRWSKIQIVTKQTGNECVTAIEIVPATPAGMRPAANVARKFASIARNQVRKKRQMAARERKVTRTIFAILLAFILTWTPYNVMVLVNTFCQSCIPDTVWSIGYWLCYVNSTINPACYALCNATFKKTFRHLLLCQYRNIGTAR
UniProt	P08173
Protein Data Bank	5dsg
GPCR-HGmod model	P08173
3D structure model	This structure is from PDB ID 5dsg.
BioLiP	BL0339919,BL0339921, BL0339920
Therapeutic Target Database	T20709, T50918
ChEMBL	CHEMBL1821
IUPHAR	16
DrugBank	BE0000405

Ligand

Name	pirenzepine
Molecular formula	C19H21N5O2
IUPAC name	11-[2-(4-methylpiperazin-1-yl)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one
Molecular weight	351.41
Hydrogen bond acceptor	5
Hydrogen bond donor	1
XlogP	0.1
Synonyms	Pirenzepina AB00053603_09 Pirenzepinum [INN-Latin] BRD-K89375097-300-06-2 SCHEMBL41705 CCG-205042 Spectrum_001378 FT-0600051 KBio1_000127 L000485 NCGC00015836-03 11-[2-(4-methylpiperazin-1-yl)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one NCGC00015836-12 3G0285N20N Pirenzepine (INN) API0006928 Prestwick2_000129 BSPBio_002945 SPBio_002117 CHEMBL9967 Tox21_110239_1 DSSTox_CID_3487 Gastrozepin KBio2_006994 LS-133128 11-[(4-Methyl-1-piperazinyl)acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one # NCGC00015836-06 11-[2-(4-methylpiperazino)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one;hydrochloride NCGC00024297-05 6H-Pyrido(2,3-b)(1,4)benzodiazepin-6-one, 5,11-dihydro-11-((4-methyl-1-piperazinyl)acetyl)- AB00053603 pirenzepinedihydrochloride BPBio1_000196 RMHMFHUVIITRHF-UHFFFAOYSA-N CAS-28797-61-7 Spectrum4_000437 D08389 ZINC19632927 DTXSID7023487 HMS2089K21 KBioSS_001858 NCGC00015836-01 11-[2-(4-Methyl-piperazin-1-yl)-acetyl]-5,11-dihydro-benzo[e]pyrido[3,2-b][1,4]diazepin-6-one NCGC00015836-09 PDSP2_000949 Pirenzepina [INN-Spanish] AC1L1J3B Prestwick0_000129 BRN 0628987 SMR000058502 CHEBI:8247 Tocris-1071 DB00670 Gasteril KBio2_001858 Lopac-P-7412 NCGC00015836-04 11-[2-(4-methylpiperazin-1-yl)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one;hydrochloride NCGC00024297-02 5,11-Dihydro-11-((4-methyl-1-piperazinyl)acetyl)-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one 6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one, 5,11-dihydro-11-[(4-methyl-1-piperazinyl)acetyl]- Pirenzepine Gastrozepin BCP12188 Prestwick3_000129 C07508 Spectrum2_001417 cid_185248 Ulcosan DSSTox_GSID_23487 Gastrozepin (TN) KBio3_002445 LS-519 11-[(4-methylpiperazin-1-yl)acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one NCGC00015836-07 2-[2-(4-methylpiperazin-1-yl)acetyl]-2,4,9-triazatricyclo[9.4.0.0;{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-10-one NINDS_000127 AB00053603-08 Pirenzepinum BRD-K89375097-300-05-4 SBI-0050935.P003 CAS-29868-97-1 Spectrum5_001344 D0T0LM EINECS 249-228-4 IDI1_000127 L-S 519 NCGC00015836-02 11-[2-(4-methylpiperazin-1-yl)-acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one NCGC00015836-10 Pirenzepin AKOS015969751 Prestwick1_000129 BSPBio_000178 SPBio_001494 Tox21_110239 DivK1c_000127 Gastrotsepin KBio2_004426 Lopac0_000962 11-((4-Methyl-1-piperazinyl)acetyl)-5,11-dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one NCGC00015836-05 11-[2-(4-methylpiperazin-1-yl)ethanoyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one;hydrochloride NCGC00024297-04 5,11-Dihydro-11-[(4-methyl-1-piperazinyl)acetyl]-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one 97P617 Pirenzepine [INN:BAN] BDBM39341 Pyrenzepine C19H21N5O2 Spectrum3_001453 CTK6I3129 UNII-3G0285N20N DSSTox_RID_77049 GTPL328 KBioGR_000794 MLS000069702 11-[2-(4-methyl-1-piperazinyl)-1-oxoethyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one;hydrochloride NCGC00015836-08 28797-61-7 PDSP1_000965 [ Show all ]
Inchi Key	RMHMFHUVIITRHF-UHFFFAOYSA-N
Inchi ID	InChI=1S/C19H21N5O2/c1-22-9-11-23(12-10-22)13-17(25)24-16-7-3-2-5-14(16)19(26)21-15-6-4-8-20-18(15)24/h2-8H,9-13H2,1H3,(H,21,26)
PubChem CID	4848
ChEMBL	CHEMBL9967
IUPHAR	328
BindingDB	39341
DrugBank	DB00670
Structure SDF download
Lipinski's druglikeness	This ligand satisfies Lipinski's rule of five.

Experimental Data

Parameter	Value	Reference	Database source
IC50	1.1 nM	PMID25275964	BindingDB
IC50	1.148 nM	PMID25275964	ChEMBL
IC50	246.8 nM	PMID9986705	ChEMBL
IC50	247.0 nM	PMID9986705	BindingDB
IC50	1047.0 nM	PMID25275964	BindingDB
IC50	1047.13 nM	PMID25275964	ChEMBL
Imax	67.0 %	PMID25275964	ChEMBL
Imax	>100.0 %	PMID25275964	ChEMBL
Ki	13.8 nM	PMID18595721	BindingDB,ChEMBL
Ki	25.1189 - 100.0 nM	PMID12049493, PMID7925952, PMID1994002, PMID9113359, PMID2043926	IUPHAR
Ki	28.0 nM	PMID1346637	PDSP,BindingDB
Ki	34.67 nM	Bioorg. Med. Chem. Lett., (1995) 5:20:2325	ChEMBL
Ki	35.0 nM	N/A	BindingDB
Ki	37.15 nM	PMID1994002	BindingDB
Ki	37.1535 nM	PMID1994002	PDSP
Ki	39.8107 nM	PMID8016895	PDSP
Ki	50.0 nM	PMID9121349	PDSP
Ki	105.0 nM	PMID23379472	BindingDB,ChEMBL

zhanglabzhanggroup.org | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218